← 治験一覧に戻る
人工膵臓による厳格な血糖コントロール
基本情報
- NCT ID
- NCT00735228
- ステータス
- 不明
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 400
- 治験依頼者名
- Kochi University
概要
Hyperglycaemia has been repeatedly associated with risk of mortality and morbidity in the intensive care unit (ICU). The evidence currently available is in favour of a 'normal ≤ 6.1 mmol/l' level for blood glucose control in ICUs according to two large randomized control trials of Van den Berghe G and is not supportive of J. Miles's viewpoint in this debate. In this study, the investigators would like to evaluate that the target of blood glucose level, whether is a normal level (80-110 mg/dL) or another level (140-160 mg/dL), should be set for the reduction of perioperative mortality and complications.
対象疾患
Pancreatic DiseaseCardiovascular Diseases
介入
Artificial pancreas(DEVICE)
依頼者(Sponsor)
実施施設 (1)
高知大学医学部附属病院
Nankoku, Japan(RECRUITING)